Last update Jan. 26, 2019

Mesotherapy

Low Risk

Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Mesotherapy involves the administration of various substances (drugs, vitamins, plant extracts, homeopathic agents ...) by multiple subcutaneous or intradermal injections, usually for cosmetic or slimming purposes, also to treat pain, venous insufficiency, androgenic alopecia and other illness (Konda 2103, Vedamurthy 2007).

There is no evidence on the effectiveness of this practice (Jayasinghe 2103, El-Domyati 2012, Sarkar 2011, Herreros 2011, Sivagnanam 2010, Atiyeh 2008, Brown 2006). Moreover, among the few existing publications in scientific journals, most of them talk about adverse effects, such as non- tuberculous mycobacterial infections (Couderc 2011, Wongkitisophon 2011, Galés 2011, Quiñones 2010, Da Mata 2010, Gutiérrez 2010, Correa 2010, Rivera 2006), cutaneous tuberculosis (Orjuela 2010), skin allergies CDC 2005), poisoning (Vukcević 2012) and others.

It is a practice without any demonstrated effectiveness, potentially harmful and very expensive (Sivagnanam 2010, Atiyeh 2008).

At latest update no published data on their compatibility with breastfeeding were found.

The risk for breastfeeding or the breastfed infant depends on the product which is injected under the skin, as it has been shown a systemic absorption and therefore the medication could be excreted through the breast milk.


See below the information of this related product:

  • Hydrolipoclasia (Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)

Alternatives

  • Cavitation ( Safe. Compatible. Minimal risk for breastfeeding and infant.)
  • Cryolipolysis ( Safe. Compatible. Minimal risk for breastfeeding and infant.)

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Mesotherapy is also known as


Group

Mesotherapy belongs to this group or family:

References

  1. Jayasinghe S, Guillot T, Bissoon L, Greenway F. Mesotherapy for local fat reduction. Obes Rev. 2013 Abstract
  2. Konda D, Thappa DM. Mesotherapy: What is new? Indian J Dermatol Venereol Leprol. 2013 Abstract
  3. El-Domyati M, El-Ammawi TS, Moawad O, El-Fakahany H, Medhat W, Mahoney MG, Uitto J. Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation. Int J Dermatol. 2012 Abstract
  4. Vukcević NP, Babić G, Segrt Z, Ercegović GV, Janković S, Aćimović L. Severe acute caffeine poisoning due to intradermal injections: mesotherapy hazard. Vojnosanit Pregl. 2012 Abstract
  5. Sarkar R, Garg VK, Mysore V. Position paper on mesotherapy. Indian J Dermatol Venereol Leprol. 2011 Abstract
  6. Herreros FO, Moraes AM, Velho PE. Mesotherapy: a bibliographical review. An Bras Dermatol. 2011 Abstract
  7. Couderc C, Carbonne A, Thiolet JM, Brossier F, Savey A, Bernet C, Ortmans C, Lecadet-Morin C, Coudière I, Aggoune M, Astagneau P, Coignard B, Cambau E. [Non-tuberculous mycobacterial infections related to esthetic care in France, 2001-2010]. Med Mal Infect. 2011 Abstract
  8. Wongkitisophon P, Rattanakaemakorn P, Tanrattanakorn S, Vachiramon V. Cutaneous Mycobacterium abscessus Infection Associated with Mesotherapy Injection. Case Rep Dermatol. 2011 Abstract
  9. Galmés-Truyols A, Giménez-Duran J, Bosch-Isabel C, Nicolau-Riutort A, Vanrell-Berga J, Portell-Arbona M, Seguí-Prat B, Gumá-Torá M, Martí-Alomar I, Rojo-Arias MÁ, Ruiz-Veramendi M. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. Enferm Infecc Microbiol Clin. 2011 Abstract
  10. Gutiérrez-de la Peña J, Ruiz-Veramendi M, Montis-Suau A, Martín-Santiago A. [Three cases of panniculitis due to Mycobacterium abscessus after mesotherapy]. Actas Dermosifiliogr. 2010 Abstract
  11. Sivagnanam G. Mesotherapy - The french connection. J Pharmacol Pharmacother. 2010 Abstract
  12. Orjuela D, Puerto G, Mejía G, Castro C, Garzón MC, García LM, Hernández E, Ribón W, Rodríguez G. Cutaneous tuberculosis after mesotherapy: report of six cases. Biomedica. 2010 Abstract
  13. Quiñones C, Ramalle-Gómara E, Perucha M, Lezaun ME, Fernández-Vilariño E, García-Morrás P, Simal G. An outbreak of Mycobacterium fortuitum cutaneous infection associated with mesotherapy. J Eur Acad Dermatol Venereol. 2010 Abstract
  14. Da Mata Jardín O, Hernández-Pérez R, Corrales H, Cardoso-Leao S, de Waard JH. [Follow-up on an outbreak in Venezuela of soft-tissue infection due to Mycobacterium abscessus associated with Mesotherapy]. Enferm Infecc Microbiol Clin. 2010 Abstract
  15. Correa NE, Cataño JC, Mejía GI, Realpe T, Orozco B, Estrada S, Vélez A, Vélez L, Barón P, Guzmán A, Robledo J. Outbreak of mesotherapy-associated cutaneous infections caused by Mycobacterium chelonae in Colombia. Jpn J Infect Dis. 2010 Abstract
  16. Atiyeh BS, Ibrahim AE, Dibo SA. Cosmetic mesotherapy: between scientific evidence, science fiction, and lucrative business. Aesthetic Plast Surg. 2008 Abstract
  17. Vedamurthy M. Mesotherapy. Indian J Dermatol Venereol Leprol. 2007 Abstract
  18. Rivera-Olivero IA, Guevara A, Escalona A, Oliver M, Pérez-Alfonzo R, Piquero J, Zerpa O, de Waard JH. [Soft-tissue infections due to non-tuberculous mycobacteria following mesotherapy. What is the price of beauty]. Enferm Infecc Microbiol Clin. 2006 Abstract
  19. Brown SA. The science of mesotherapy: chemical anarchy. Aesthet Surg J. 2006 Abstract
  20. Centers for Disease Control and Prevention (CDC). Outbreak of mesotherapy-associated skin reactions--District of Columbia area, January-February 2005. MMWR Morb Mortal Wkly Rep. 2005 Abstract

Total visits

72,393

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM